Home Top Movers Savara Inc. (SVRA) stock is rising today: What’s Going On?

Savara Inc. (SVRA) stock is rising today: What’s Going On?

Shares of Savara Inc. (SVRA) stock were rising today on May 26, 2021, after falling as much as 2.98% at the previous closing. SVRA stock price saw a surge of 4.29% to reach $1.70 a share as of this writing. There is no news other than the announcement of the presentation date by Savara management. Let’s deep dive to explore more of it.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What’s Happening?

Savara Inc. (SVRA) is a clinical-stage biopharmaceutical company focused on the treatment of lung diseases. SVRA stock today announced that its management will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 10:00 AM ET / 7:00 AM PT.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

On May 14, 2021, SVRA stock did announce the new Employment inducement grant by the compensation committee of its board of directors. According to this grant, the newly hired employee would be able to purchase 175,000 shares of SVRA common stock and restricted stock units that cover 100,000 shares of the SVRA common stock. The exercise price for this option was $1.62 per share.

Financial View of SVRA stock:

On May 13, 2021, SVRA stock announced the first quarter of 2021 financial results the highlights of which are given below.

  • Net loss attributable to Savara’s common stockholders was $10.2 million, or $(0.13) per share for the first quarter of 2021 as compared to  $15.4 million, or $(0.27) per share net loss attributable to Savara’s common stockholders.
  • Savara spent $7.6 million in research and development expenses in the first quarter of 2021 which is $5.6 million or 42.5% less than the $13.2 million research and development expenses in the same quarter of 2020. The acquisition cost of $5.4 million for inhaled liposomal ciprofloxacin (Apulmiq) was the main reason for this decrease.
  • General and administrative expenses reduced from $3.0 million in the first quarter of 2020 to $2.8 million in the first quarter of 2021 due to noncash stock-based compensation as well as personnel costs for the reported quarter.
  • Savara stock reported $192.7 million cash, cash equivalents, and short-term investment as of March 31, 2020, and its debt was approximately $25 million at that time.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

SVRA stock price was gaining today after facing the bearish sentiment at previous trading. Investors eyeing Savara stock are waiting for the 2nd June presentation by SVRA. In short, deep fundamental, as well as technical analysis, is necessary before adding Savara stock to the portfolio.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam